title: Omalizumab treatment in 2 cases of refractory heat urticaria.
authors.forename: F
authors.initials: F
authors.lastname: Carballada
authors.forename: R
authors.initials: R
authors.lastname: Nuñez
authors.forename: J
authors.initials: J
authors.lastname: Martin-Lazaro
authors.forename: Y
authors.initials: Y
authors.lastname: Juárez
authors.forename: I
authors.initials: I
authors.lastname: Castiñeira
authors.forename: F
authors.initials: F
authors.lastname: Carballada
authors.forename: R
authors.initials: R
authors.lastname: Nuñez
authors.forename: J
authors.initials: J
authors.lastname: Martin-Lazaro
authors.forename: Y
authors.initials: Y
authors.lastname: Juárez
authors.forename: I
authors.initials: I
authors.lastname: Castiñeira
authors.forename: L
authors.initials: L
authors.lastname: Fernández
authors.forename: M
authors.initials: M
authors.lastname: Boquete
mesh_terms: D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006358:Hot Temperature; D006801:Humans; D008875:Middle Aged; D000069444:Omalizumab; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab